APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anthelmintic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anthelmintic Drugs Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchAnthelmintic Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Anthelmintic Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Anthelmintic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anthelmintic Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anthelmintic Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Anthelmintic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anthelmintic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anthelmintic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anthelmintic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anthelmintic Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anthelmintic Drugs market include Sun Pharmaceutical Industries, Johnson & Johnson, Novartis, Merck, Pfizer, Bayer, Mankind Pharma and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anthelmintic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anthelmintic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anthelmintic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anthelmintic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Anthelmintic Drugs Segment by Company

Sun Pharmaceutical Industries

Johnson & Johnson

Novartis

Merck

Pfizer

Bayer

Mankind Pharma

Cipla

Anthelmintic Drugs Segment by Type

Oral Drugs

Injectables

Anthelmintic Drugs Segment by Application

For Human

For Animal

Anthelmintic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anthelmintic Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anthelmintic Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anthelmintic Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Anthelmintic Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anthelmintic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anthelmintic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anthelmintic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anthelmintic Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anthelmintic Drugs industry.

Chapter 3: Detailed analysis of Anthelmintic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anthelmintic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anthelmintic Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anthelmintic Drugs Industry Trends Table 2. Anthelmintic Drugs Industry Drivers Table 3. Anthelmintic Drugs Industry Opportunities and Challenges Table 4. Anthelmintic Drugs Industry Restraints Table 5. Global Anthelmintic Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anthelmintic Drugs Revenue Share by Company (2021-2026) Table 7. Global Anthelmintic Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Anthelmintic Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Anthelmintic Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Anthelmintic Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anthelmintic Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Anthelmintic Drugs Company, Product Type & Application Table 13. Global Anthelmintic Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Drugs Table 18. Significant Companies of Injectables Table 19. Global Anthelmintic Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Anthelmintic Drugs Sales Volume by Type (2021-2026) & (k units) Table 21. Global Anthelmintic Drugs Sales Volume by Type (2027-2032) & (k units) Table 22. Global Anthelmintic Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Anthelmintic Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Anthelmintic Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Anthelmintic Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Anthelmintic Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Anthelmintic Drugs Sales Value Share by Type (2021-2026) Table 28. Global Anthelmintic Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of For Human Table 30. Significant Companies of For Animal Table 31. Global Anthelmintic Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Anthelmintic Drugs Sales Volume by Application (2021-2026) & (k units) Table 33. Global Anthelmintic Drugs Sales Volume by Application (2027-2032) & (k units) Table 34. Global Anthelmintic Drugs Sales Volume Share by Application (2021-2026) Table 35. Global Anthelmintic Drugs Sales Volume Share by Application (2027-2032) Table 36. Global Anthelmintic Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Anthelmintic Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Anthelmintic Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Anthelmintic Drugs Sales Value Share by Application (2021-2026) Table 40. Global Anthelmintic Drugs Sales Value Share by Application (2027-2032) Table 41. Global Anthelmintic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Anthelmintic Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Anthelmintic Drugs Sales Market Share by Region (2021-2026) Table 44. Global Anthelmintic Drugs Sales by Region (2027-2032) & (k units) Table 45. Global Anthelmintic Drugs Sales Market Share by Region (2027-2032) Table 46. Global Anthelmintic Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Anthelmintic Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Anthelmintic Drugs Sales Value Share by Region (2021-2026) Table 49. Global Anthelmintic Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Anthelmintic Drugs Sales Value Share by Region (2027-2032) Table 51. Global Anthelmintic Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Anthelmintic Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Anthelmintic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Anthelmintic Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Anthelmintic Drugs Sales by Country (2021-2026) & (k units) Table 56. Global Anthelmintic Drugs Sales Market Share by Country (2021-2026) Table 57. Global Anthelmintic Drugs Sales by Country (2027-2032) & (k units) Table 58. Global Anthelmintic Drugs Sales Market Share by Country (2027-2032) Table 59. Global Anthelmintic Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Anthelmintic Drugs Sales Value Market Share by Country (2021-2026) Table 61. Global Anthelmintic Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Anthelmintic Drugs Sales Value Market Share by Country (2027-2032) Table 63. Sun Pharmaceutical Industries Company Information Table 64. Sun Pharmaceutical Industries Business Overview Table 65. Sun Pharmaceutical Industries Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Industries Anthelmintic Drugs Product Portfolio Table 67. Sun Pharmaceutical Industries Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Anthelmintic Drugs Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Novartis Anthelmintic Drugs Product Portfolio Table 77. Novartis Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Merck Anthelmintic Drugs Product Portfolio Table 82. Merck Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Pfizer Anthelmintic Drugs Product Portfolio Table 87. Pfizer Recent Development Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bayer Anthelmintic Drugs Product Portfolio Table 92. Bayer Recent Development Table 93. Mankind Pharma Company Information Table 94. Mankind Pharma Business Overview Table 95. Mankind Pharma Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Mankind Pharma Anthelmintic Drugs Product Portfolio Table 97. Mankind Pharma Recent Development Table 98. Cipla Company Information Table 99. Cipla Business Overview Table 100. Cipla Anthelmintic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Cipla Anthelmintic Drugs Product Portfolio Table 102. Cipla Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Anthelmintic Drugs Distributors List Table 106. Anthelmintic Drugs Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Anthelmintic Drugs Product Image Figure 2. Global Anthelmintic Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anthelmintic Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anthelmintic Drugs Sales (2021-2032) & (k units) Figure 5. Global Anthelmintic Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Anthelmintic Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Drugs Image Figure 10. Injectables Image Figure 11. Global Anthelmintic Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Anthelmintic Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Anthelmintic Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Anthelmintic Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Anthelmintic Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Anthelmintic Drugs Sales Value Share by Type (2021-2032) Figure 17. For Human Image Figure 18. For Animal Image Figure 19. Global Anthelmintic Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Anthelmintic Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Anthelmintic Drugs Sales Volume Share by Application (2021-2032) Figure 22. Global Anthelmintic Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Anthelmintic Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Anthelmintic Drugs Sales Value Share by Application (2021-2032) Figure 25. Global Anthelmintic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Anthelmintic Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Anthelmintic Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Anthelmintic Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Anthelmintic Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. North America Anthelmintic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Anthelmintic Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Anthelmintic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Anthelmintic Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Anthelmintic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Anthelmintic Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. South America Anthelmintic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Anthelmintic Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Anthelmintic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Anthelmintic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Anthelmintic Drugs Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Anthelmintic Drugs Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Drugs
  • Injectables
Applications
  • For Human
  • For Animal
Companies covered
  • Sun Pharmaceutical Industries
  • Johnson & Johnson
  • Novartis
  • Merck
  • Pfizer
  • Bayer
  • Mankind Pharma
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anthelmintic Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Anthelmintic Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Anthelmintic Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anthelmintic Drugs Market Dynamics
  1. 2.1 Anthelmintic Drugs Industry Trends
  2. 2.2 Anthelmintic Drugs Industry Drivers
  3. 2.3 Anthelmintic Drugs Industry Opportunities and Challenges
  4. 2.4 Anthelmintic Drugs Industry Restraints
3 Anthelmintic Drugs Market by Company
  1. 3.1 Global Anthelmintic Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Anthelmintic Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Anthelmintic Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Anthelmintic Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Anthelmintic Drugs Company Ranking (2024-2026)
  6. 3.6 Global Anthelmintic Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Anthelmintic Drugs Company Product Type and Application
  8. 3.8 Global Anthelmintic Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anthelmintic Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anthelmintic Drugs Market by Type
  1. 4.1 Anthelmintic Drugs Type Introduction
  2. 4.1.1 Oral Drugs
  3. 4.1.2 Injectables
  4. 4.2 Global Anthelmintic Drugs Sales Volume by Type
  5. 4.2.1 Global Anthelmintic Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anthelmintic Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Anthelmintic Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Anthelmintic Drugs Sales Value by Type
  9. 4.3.1 Global Anthelmintic Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anthelmintic Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Anthelmintic Drugs Sales Value Share by Type (2021-2032)
5 Anthelmintic Drugs Market by Application
  1. 5.1 Anthelmintic Drugs Application Introduction
  2. 5.1.1 For Human
  3. 5.1.2 For Animal
  4. 5.2 Global Anthelmintic Drugs Sales Volume by Application
  5. 5.2.1 Global Anthelmintic Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Anthelmintic Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Anthelmintic Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Anthelmintic Drugs Sales Value by Application
  9. 5.3.1 Global Anthelmintic Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Anthelmintic Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Anthelmintic Drugs Sales Value Share by Application (2021-2032)
6 Anthelmintic Drugs Regional Sales and Value Analysis
  1. 6.1 Global Anthelmintic Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anthelmintic Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Anthelmintic Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Anthelmintic Drugs Sales by Region (2027-2032)
  5. 6.3 Global Anthelmintic Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anthelmintic Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anthelmintic Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anthelmintic Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Anthelmintic Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anthelmintic Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Anthelmintic Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anthelmintic Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Anthelmintic Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anthelmintic Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anthelmintic Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anthelmintic Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Anthelmintic Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anthelmintic Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anthelmintic Drugs Sales Value Share by Country, 2025 VS 2032
7 Anthelmintic Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Anthelmintic Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anthelmintic Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anthelmintic Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Anthelmintic Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Anthelmintic Drugs Sales by Country (2027-2032)
  6. 7.4 Global Anthelmintic Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anthelmintic Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anthelmintic Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anthelmintic Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anthelmintic Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anthelmintic Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Anthelmintic Drugs Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Anthelmintic Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Anthelmintic Drugs Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Anthelmintic Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Anthelmintic Drugs Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Anthelmintic Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Anthelmintic Drugs Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Anthelmintic Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Anthelmintic Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Anthelmintic Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Anthelmintic Drugs Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Mankind Pharma
  38. 8.7.1 Mankind Pharma Company Information
  39. 8.7.2 Mankind Pharma Business Overview
  40. 8.7.3 Mankind Pharma Anthelmintic Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mankind Pharma Anthelmintic Drugs Product Portfolio
  42. 8.7.5 Mankind Pharma Recent Developments
  43. 8.8 Cipla
  44. 8.8.1 Cipla Company Information
  45. 8.8.2 Cipla Business Overview
  46. 8.8.3 Cipla Anthelmintic Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cipla Anthelmintic Drugs Product Portfolio
  48. 8.8.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anthelmintic Drugs Value Chain Analysis
  2. 9.1.1 Anthelmintic Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anthelmintic Drugs Sales Mode & Process
  6. 9.2 Anthelmintic Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anthelmintic Drugs Distributors
  9. 9.2.3 Anthelmintic Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst